In our work, EFL1 reduced liver metastasis and mesenteric re-metastasis of breast cancer cells, enhanced liver function and mitigated ascites in breast cancer SHI mice, reflecting the potential of EFL1 in treating breast cancer liver metastasis. Here, EFL1 is linked to breast cancer.